The global D-dimer Testing Market is projected to grow at a CAGR of 4.59% from 2024 to 2032, driven by increasing diagnostic awareness, expanding healthcare infrastructure, and technological ...

Plasma d-dimer levels to rule out pulmonary embolism in hospitalized COVID-19 patients is not the right assay to use, new research suggests. Most patients already have levels greater than 0.05 μg/mL.

Specifically, the considerable increase in efficiency with the use of adapted D-dimer thresholds was highest in the patient subgroups, where efficiency could be increased with up to 3-fold, yet ...

Use of clinical decision rules in conjunction with D-dimer thresholds adjusted higher based on either age or pretest probability is acceptably safe for ruling out acute pulmonary embolism (PE) without ...

Level 1: Likely reliable evidence D-dimer plus multidetector CT (D-dimer/CT) is as effective as D-dimer/CT plus venous compression ultrasound (US) for identifying pulmonary embolism (PE) and short ...

The four tests had "comparable accuracy" for the diagnosis of PJI. Sensitivity (ability to detect PJI when present) was 81.3% for D-dimer, 90.4% for CRP, 73.9% for ESR, and 74.7% for fibrinogen.

For patients without and with PE, the median D-dimer values were 1.0 and 6.1 µg/mL, respectively; D-dimer values ranged from 0.2 to 128 µg/mL and from 0.5 to more than 10,000 µg/mL, respectively.

Preliminary scientific report. Lin, K., Xu, K., Daoust, R., et al. (2022) Diagnostic accuracy of age-adjusted D-dimer for pulmonary embolism among Emergency Department patients with suspected SARS ...

A new study investigating D-dimer testing in patients who are at higher risk of pulmonary embolism (PE) has been published in the February issue of Academic Emergency Medicine (AEM), the peer ...